Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PN-881 in Healthy Subjects.
Clinical trial NCT07153146 · COMPLETED
Trial details
- NCT number
- NCT07153146
- Sponsor
- Protagonist Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-07
- Primary completion
- 2026-07-29
- Enrollment
- 146
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.